title: Induction of immunosuppression with OKT3 following heart transplantation: kidney function as a criterion for control of protocol duration.
authors.affiliation: Heart Transplant Program, Hospital Juan Canalejo, La Coruña, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: Rodríguez
authors.forename: M G
authors.initials: MG
authors.lastname: Crespo-Leiro
authors.forename: M J
authors.initials: MJ
authors.lastname: Paniagua
authors.forename: J
authors.initials: J
authors.lastname: Muñiz
authors.forename: L F
authors.initials: LF
authors.lastname: Hermida
authors.forename: S
authors.initials: S
authors.lastname: Fojón
authors.forename: J J
authors.initials: JJ
authors.lastname: Cuenca
authors.forename: A
authors.initials: A
authors.lastname: Juffé-Stein
authors.forename: A
authors.initials: A
authors.lastname: Castro-Beiras
mesh_terms: D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007677:Kidney Function Tests; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012189:Retrospective Studies
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine